The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8+ cytotoxic T lymphocytes

AIDS Research and Human Retroviruses

Volumn 15, Issue 4, 1999, Pages 365-373

  Koopman, Gerrit ^a   Haaksma, Antonius G M ^a   Ten Velden, Jos ^b   Hack, C Erik ^c   Heeney, Jonathan L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU HYBRIDIZATION; LYMPH NODE BIOPSY; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; GRANZYMES; HIV-1; HUMANS; IMMUNITY, NATURAL; LYMPH NODES; PAN TROGLODYTES; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033046367     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311330     Document Type: Article

References (63)

1. Fauci AS: The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988;239;617-622.
2. Lifson AR, Rutherford GW, and Jaffe HW: The natural history of human immunodeficiency virus infection. J Infect Dis 1988;158: 1360-1367.
3. van Noesel CJ, Gruters RA, Terpstra FG, Schellekens PT, van Lier RA and Miedema F: Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 1990;86:293-299.
4. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, and Volberding PA: HIV viral load markers in clinical practice. Nature Med 1996;2:625-629.
5. Haynes BF, Pantaleo G, and Fauci AS: Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996;271:324-328. [See comments]
6. Shearer GM and Clerici M: Early T-helper cell defects in HIV infection. AIDS 1991;5:245-253.
7. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, and Fauci AS: Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective detect in soluble antigen recognition. N Engl J Med 1985; 313:79-84.
8. + T helper cell depletion occurs. J Clin Invest 1988;82:1908-1914.
9. Garbrecht FC, Siskind GW, and Weksler ME: Lymphocyte transformation induced by autologous cells. XVIII. Impaired autologous mixed lymphocyte reaction in subjects with AIDS-related complex. Clin Exp Immunol 1987;67:245-251.
10. Shearer GM, Bernstein DC, Tung KS, Via CS, Redfield R, Salahuddin SZ, and Gallo RC: A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986;137:2514-2521.
11. Groux H, Torpier G, Monte D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
12. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, and Miedema F: Programmed death of T cells in HIV-1 infection. Science 1992;257:217-219.
13. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T, and Montagnier L: Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocytes activation and with disease progression. J Immunol 1996;156:3509-3520.
14. Estaquier J, Tanaka M, Suda T, Nagata S, Golstein P, and Ameisen JC: Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: Differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996;87:4959-4966.
15. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
16. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
17. Tenner-Racz K, Racz P, Bofill M, Schulz-Meyer A, Dietrich M, Kern P, Weber J, Pinching AJ, Veronese-Dimarzo F, Popovic M, et al.: HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDs. Am J Pathol 1986;123:9-15.
18. Racz P, Tenner-Racz K, van Vloten F, Schmidt H, Dietrich M, Gluckman JC, Letvin NL, and Janossy G: Lymphatic tissue changes in AIDS and other retrovirus infections: Tools and insights. Lymphology 1990;23:85-91.
19. Tenner-Racz K: Human immunodeficiency virus associated changes in germinal centers of lymph nodes and relevance to impaired B-cell function. Lymphology 1988;21:36-43.
20. Armstrong JA and Home R: Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984;2: 370-372.
21. Tenner-Racz K, Racz P, Dietrich M, and Kern P: Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet 1985;1:105-106.
22. Fox CH, Tenner-Racz K, Racz P, Firpo A, Pizzo PA, and Fauci AS: Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991;164:1051-1057. [Published erratum appears in J Infect Dis 1992;165(6):1161]
23. Reinhart TA, Rogan MJ, Viglianti GA, Rausch DM, Eiden LE, and Haase AT: A new approach to investigating the relationship between productive infection and cytopathicity in vivo. Nature Med 1997;3:218-221.
24. Janossy G, Pinching AJ, Bofill M, Weber J, McLaughlin JE, Ornstein M, Ivory K, Harris JR, Favrot M, and MacDonald-Burns DC: An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol 1985;59:257-266.
25. Piris MA, Rivas C, Morente M, Rubio C, Martin C, and Olivia H: Persistent and generalized lymphadenopathy: A lesion of follicular dendritic cells? An immunohistologic and ultrastructural study. Am J Clin Pathol 1987;87:716-724.
26. Wood GS, Garcia CF, Dorfman RF, and Warnke RA: The immunohistology of follicle lysis in lymph node biopsies from homosexual men. Blood 1985;66:1092-1097.
27. Pantaleo G, Graziosi C, Demarest JF, Cohen OJ, Vaccarezza M, Gantt K, Muro-Cacho C, and Fauci AS: Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 1994;140:105-130.
28. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 1993;262:1011-1018.
29. Koopman G and Pals ST: Cellular interactions in the germinal center: Role of adhesion receptors and significance for the pathogenesis of AIDS and malignant lymphoma. Immunol Rev 1992;126: 21-45.
30. Heeney JL: AIDS: A disease of impaired Th-cell renewal? Immunol Today 1995;16:515-520.
31. Smyth MJ and Trapani JA: Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol Today 1995;16:202-206.
32. Jenne DE and Tschopp J: Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 1988;103:53-71.
33. Koopman G, Wever PC, Ramkema MD, Bellot F, Reiss P, Keehnen RM, Ten Berge IJ, and Pals ST: Expression of granzyme B by cytotoxic T lymphocytes in the lymph nodes of HIV-infected patients. AIDS Res Hum Retroviruses 1997;13:227-233.
34. Tenner-Racz K, Racz P, Thome C, Meyer CG, Anderson PJ, Schlossman SF, and Letvin NL: Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. Am J Pathol 1993;142:1750-1758.
35. Bofill M, Gombert W, Borthwick NJ, Akbar AN, McLaughlin JE, Lee CA, Johnson MA, Pinching AJ, and Janossy G: Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HTV-1+ patients. Am J Pathol 1995;146:1542-1555.
36. Johnson BJ, Stone GA, Godec MS, Asher DM, Gajdusek DC and Gibbs C Jr: Long-term observations of human immunodeficiency virus-infected chimpanzees. AIDS Res Hum Retroviruses 1993;9: 375-378. [Published erratum appears in AIDS Res Hum Retroviruses 1993;9(6):579]
37. Novembre FJ, Saucier M, Anderson DC, Klumpp SA, O'Neil SP, Brown C, Hart CE, Guenthner PC, Swenson RB, and McClure HM: Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 1997;71:4086-4091.
38. Gougeon ML, Lecouer H, Boudet F, Ledru E, Marzabal S, Boullier S, Roue R, Nagata S, and Heeney J: Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol 1997;158:2964-2976.
39. Heeney J, Jonker R, Koornstra W, Dubbes R, Niphuis H, Di Rienzo AM, Gougeon ML, and Montagnier L: The resistance of HlV-in-fected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 1993;22: 194-200.
40. Schuitemaker H, Meyaard L, Kootstra NA, Dubbes R, Otto SA, Tersmette M, Heeney JL, and Miedema F: Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1 -infected chimpanzees correlates with absence of monocytotropic variants. J Infect Dis 1993;168:1140-1147. [See comments]
41. ten Haaft P, Cornelissen M, Goudsmit J, Koornstra W, Dubbes R, Niphuis H, Peeters M, Thiriart C, Bruck C, and Heeney JL: Virus load in chimpanzees infected with human immunodeficiency virus type 1: Effect of pre-exposure vaccination. J Gen Virol 1995;76:1015-1020.
42. Kestens L, Vingerhoets J, Peeters M, Vanham G, Vereecken C, Penne G, Niphuis H, van Eerd P, van der Groen G, Gigase P, et al.: Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Infect Dis 1995;172:957-963.
43. Niedrig M, Rabanus JP, L'Age Stehr J, Gelderblom HR, and Pauli G: Monoclonal antibodies directed against human immunodeficiency virus (HIV) Gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus. J Gen Virol 1988;69:2109-2114.
44. Naiem M, Gerdes J, Abdulaziz Z, Stein H, and Mason DY: Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol 1983;36:167-175.
45. Spaeny-Dekking EH, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJ, Middeldorp JM, Huisman HG, Froelich CJ, and Hack CE: Extracellular granzymes A and B in humans: Detection of native species during CTL responses in vitro and in vivo. J Immunol 1998;160:3610-3616.
46. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, and Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993;177: 897-904.
47. Bogers WMJM, Koornstra W, Dubbes R, Ten Haaft P, Laman JD, Jhagjhoorsingh SS, Haaksma T, Niphuis H, Farrar G, Norley S, Schuitemaker H, Goudsmit J, Hunsmann G, Heeney JL, and Wigzell H: Characteristics of primary infection of a European human immunodeficiency virus type 1 clade B isolate in chimpanzees. J Gen Virol 1999;79:2895-2903.
48. Peeters M, Janssens W, Vanden-Haesevelde M, Fransen K, Willems B, Heyndrickx L, Kestens L, Piot P, Van-der Groen G, and Heeney J: Virologie and serologic characteristics of a natural chimpanzee lentivirus infection. Virology 1995;211:312-315.
49. Zinkernagel RM and Hengartner H: T-cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS. Immunol Today 1994;15:262-268.
50. Jhagjhoorsingh SS, Koopman G, Mooij P, Haaksma AGM, Teeuwsen VJP, Voss G, Bontrop RE, and Heeney JL: CTL in HIV-1 infected chimpanzees recognize conserved epitopes associated with long term survival in humans. J Immunol 1999 (in press).
51. Saksela K, Muchmore E, Girard M, Fultz P, and Baltimore D: High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J Virol 1993;67:7423-7427.
52. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332: 201-208.
53. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, et al.: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332: 209-216.
54. Levy JA, Mackewicz CE, and Barker E: Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996;17:217-224.
55. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, and Lusso P: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as a major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270:1811-1815.
56. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
57. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, and Sodroski J: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (London) 1996;384: 179-183.
58. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature (London) 1996;381:667-673.
59. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85: 1149-1158.
60. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, McMichael AJ, and Rowland-Jones S: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997;3:212-217.
61. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, and Shaw GM: Antiviral pressure exerted by HIV-1 -specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997;3:205-211.
62. Schuurman HJ, Joling P, van Wichen DF, Rademakers LH, Broekhuizen R, de Weger RA, van den Tweel JG, and Goudsmit J: Follicular dendritic cells and infection by human immunodeficiency virus type 1, a crucial target cell and virus reservoir. Curr Top Microbiol Immunol 1995;201:161-188.
63. Gray D, Kosco M, and Stockinger B: Novel pathways of antigen presentation for the maintenance of memory. Int Immunol 1991;3:141-148.